← Open Payments lookup

JADEN HYSLIP: Open Payments

NPI 1104509892 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,131 in 106 payments from 20 companies in 2025. Trend: 2023 $1,935 · 2024 $2,080 · 2025 $2,131

Food & beverage: $2,131
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$399
Otsuka America Pharmaceutical, Inc.19$370
Janssen Pharmaceuticals, Inc7$253
Teva Pharmaceuticals USA, Inc.19$229
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$164
Vanda Pharmaceuticals Inc.6$132
Alkermes, Inc.6$127
Lundbeck LLC6$95
Bausch Health US, LLC2$46
E.R. Squibb & Sons, L.L.C.2$43

Products named: INGREZZA, REXULTI, SPRAVATO, CAPLYTA, FANAPT, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across NY — which companies pay providers there.